Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Jun 2025 for VALBIOTIS, €15k. Read the official filing
Filing timeline
BuySalePascal Sirvent
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +2.3%Entry €0.78 · Close at T+365 €0.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Pascal Sirvent: trading record in brief
This profile gathers the share dealings of Pascal Sirvent in Valbiotis, where the filings describe the role as senior executive. In total, 3 filings cover trades dated from 14 January 2021 to 25 June 2025.
No open-market sale appears; the market trades are 1 purchase worth €15k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 option exercises. In 2025 alone, the filings show 1 purchase and no sales.
The latest filing, published on 26 June 2025, reports an open-market purchase of €15k in Valbiotis. This summary is built from AMF disclosures alone and does not predict where the share price will go.
Companies and markets linked to Pascal Sirvent
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
18,000 shares@ €0.816532.2% of flowActionEuronext Growth ParisISIN FR00132548512025DD1044710
Canonical exit: 23 Sept 2025 (T+90)
2,000 shares@ €2.5811.3% of flowBSPCEEuronext Growth ParisISIN FR00132548512021DD763258
10,000 shares@ €2.5856.5% of flowBSPCEEuronext Growth ParisISIN FR00132548512021DD763256
3 of 3 declarations
